Trials / Unknown
UnknownNCT06293885
Pleurodesis Using Hypertonic Glucose
PLeurodesis Using Hypertonic Glucose Administration to Treat Post-operative Air Leaks Following Lung Resection Surgery (PLUG): Phase II Randomized Feasibility Trial
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Air leaks from unhealed lung tissue following lung resection for benign or malignant lesions are one of the most common complications following thoracic surgery, occurring after 10% of major lung resections. The purpose of this study is to investigate the efficacy of intrapleural administration of Dextrose 50% to resolve air leaks after pulmonary resection.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Dextrose 50 | a solution of 50% glucose (D50) will be injected into your pleural space |
| OTHER | Standard of Care - No Dextrose 50 | Standard of Care |
Timeline
- Start date
- 2024-03-30
- Primary completion
- 2025-04-30
- Completion
- 2025-04-30
- First posted
- 2024-03-05
- Last updated
- 2024-03-05
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT06293885. Inclusion in this directory is not an endorsement.